                         SEQUENCE LISTING

<110>  Eli Lilly and Company
 
<120>  NOVEL COMPOUND FOR TREATMENT OF SEVERE HYPOGLYCEMIA

<130>  X19933

<150>  61/917597
<151>  2013-12-18

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  1

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  2
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa at position 16 is 2-aminoisobutyric acid

<220>
<221>  MOD_RES
<222>  (40)..(40)
<223>  AMIDATION

<400>  2

His Ala Gln Gly Thr Phe Leu Ser Asp Tyr Ser Lys Tyr Leu Asp Xaa 
1               5                   10                  15      


Lys Lys Ala Gln Glu Phe Val Glu Trp Leu Leu Lys Thr Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Lys Ser Lys 
        35                  40  


<210>  3
<211>  30
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  AMIDATION

<400>  3

His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly 
1               5                   10                  15      


Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Lys Gly Arg 
            20                  25                  30  


<210>  4
<211>  42
<212>  PRT
<213>  Homo sapiens

<400>  4

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
        35                  40          


